Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.100108
Revised: October 23, 2024
Accepted: November 8, 2024
Published online: January 27, 2025
Processing time: 142 Days and 5.6 Hours
In this manuscript, I comment on the article by Pospisilova et al published in the recent issue of the journal, in which selective embolization was used to treat anorectal hemangioma, a rare disease causing lower gastrointestinal bleeding. Anorectal hemangioma can easily be mistaken; for example, the patient in this case was previously misdiagnosed with ulcerative colitis. Choosing the appro
Core Tip: The incidence rate of anorectal hemangioma is low, and it is easy to misdiagnose. Colonoscopy, computerized tomography, magnetic resonance imaging, and other tests are helpful for diagnosis. The selection and results of examinations are crucial for doctors to make correct medical decisions. After comprehensive examinations and a clear diagnosis, selective embolization can alleviate patients’ symptoms and improve their quality of life.
- Citation: Wen PH, Hu B. Selective embolization can effectively alleviate bleeding symptoms in patients with anorectal hemangioma. World J Gastrointest Surg 2025; 17(1): 100108
- URL: https://www.wjgnet.com/1948-9366/full/v17/i1/100108.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.100108
Recently, Pospisilova et al[1] reported a case in which selective embolization was used to treat anorectal hemangioma. Hemangiomas occur less frequently in the gastrointestinal tract; gastrointestinal hemangiomas predominantly occur in the small intestine and are characterized by gastrointestinal bleeding[2]. Gastrointestinal hemangiomas can exist alone or in various syndromes, such as blue rubber bleb nevus, Maffuci, and Klippel-Trenaunay-Weber[3]. Therefore, observing whether there are lesions on the skin of the patient’s mouth, head, neck, or perianal area can provide a basis for differential diagnosis. Anorectal hemangioma is characterized mainly by chronic rectal bleeding, which can lead to secondary sideropenic anemia. Owing to misdiagnosis as hemorrhoids or ulcerative colitis, diagnosis and treatment are often delayed[4]. For example, the patient in this case was previously misdiagnosed with ulcerative colitis, and it took 8 years for the patient to receive an accurate diagnosis.
According to one report, patients with gastrointestinal hemangiomas wait an average of 19 years between initial symptoms and final diagnosis[5]. In this case, a clear diagnosis was obtained through inquiries about chief complaints, a history of present illness, family history and examinations, including colonoscopy, computerized tomography (CT), magnetic resonance imaging (MRI) and serology, which shortened the time from initial symptoms to final diagnosis for this patient. Submucosal venous dilation and engorgement can be observed via colonoscopy. Both CT and MRI can reveal thickened intestinal walls and submucosal lesions. Atypical pelvic phleboliths can be found on CT, and signal voids can be found on MRI[6]. The MRI features of anorectal hemangioma also include low signals on T1-weighted images and high signals on T2-weighted images[7]. These imaging findings are present in the patient in this case, providing a reference for selecting subsequent treatment. In addition to colonoscopy, CT and MRI, Aylward et al[8] suggested that patients with rectal hemangiomas should undergo mesenteric angiography to clarify the vascular supply of the lesion and make accurate clinical decisions. Some researchers believe that the possible presence of multiple thrombi in the supply vessels can lead to a low positive rate on angiography[9]. Further research is needed to determine whether patients with anorectal hemangioma should undergo routine mesenteric angiography.
The treatment of anorectal hemangioma includes medication, endoscopic therapy, and surgery. When doctors make treatment decisions, it is necessary to consider the size, location, extent of the lesion, transmural involvement, and extracolonic organ involvement. The treatment for patients without overt symptoms consists of observation and follow-up. The need for iron supplementation or blood transfusions can be considered based on the degree of anemia. The patient in this case had to undergo blood transfusions due to intermittent rectal bleeding and symptomatic anemias. Although the patient did not need blood transfusions after selective embolization, he still required parenteral iron therapy. Tranexamic acid may be useful for this purpose. Patients treated with tranexamic acid do not require further blood or iron transfusions for over two years[10]. When the condition permits, anterior rectal resection and coloanal anastomosis with sphincter preservation are preferred for anorectal hemangiomas. Surgical treatment may lead to a high risk of fecal incontinence due to the large size of the lesion; therefore, sclerosing injection is a better choice. Patients who choose sclerosing injection to treat rectal hemangiomas undergo routine mesenteric angiography during surgery. Pai et al[11] reported that patients who choose surgical treatment to cure small intestinal or colorectal hemangiomas can also undergo mesenteric angiography before surgery. Its main purpose is to prevent the omission of lesions during surgery and reduce the recurrence rate of chronic bleeding. Neither drug therapy nor endoscopic therapy can completely remove the lesion; thus, there is a risk of recurrent bleeding. According to the report by Wang et al[9], patients may require frequent blood transfusions due to incomplete lesion resection and persistent or even aggravated rectal bleeding after sclerosing injection. Therefore, regular follow-up is necessary.
In general, if a patient has experienced unexplained recurrent rectal bleeding since childhood with significant vascular dilation under colonoscopy, gastrointestinal hemangioma, a rare disease, needs to be considered[12]. Serology tests, gastrointestinal endoscopy, CT, and MRI, can assist in diagnosing and excluding other diseases, such as hemorrhoids and ulcerative colitis. When making medical decisions, it is necessary to consider the size, location, extent, presence of transmural lesions and extraintestinal organ involvement, such as the bladder. Tranexamic acid may be useful for detecting bleeding symptoms. With regular follow-up, selective embolization can alleviate patients’ bleeding symptoms and improve their quality of life.
| 1. | Pospisilova B, Frydrych J, Krajina A, Örhalmi J, Kajzrlikova IM, Vitek P. Anorectal hemangioma, a rare cause of lower gastrointestinal bleeding, treated with selective embolization: A case report. World J Gastrointest Surg. 2024;16:2735-2741. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 4] [Reference Citation Analysis (1)] |
| 2. | Durer C, Durer S, Sharbatji M, Comba IY, Aharoni I, Majeed U. Cavernous Hemangioma of the Small Bowel: A Case Report and Literature Review. Cureus. 2018;10:e3113. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 6] [Cited by in RCA: 12] [Article Influence: 1.5] [Reference Citation Analysis (0)] |
| 3. | Mirioglu S, Cavus B, Iliaz R, Besisik F. Diffuse Cavernous Hemangioma of the Colon. Acta Gastroenterol Belg. 2016;79:393-394. [PubMed] |
| 4. | Sood R, Chilkunda D, Brittenden J, Vani D. Chronic haematochezia caused by diffuse cavernous haemangioma of the rectum. J Gastrointestin Liver Dis. 2013;22:10. [PubMed] |
| 5. | Oner Z, Altaca G. Diffuse cavernous rectal hemangioma--clinical appearance, diagnostic modalities and sphincter saving approach to therapy: report of 2 and a collective review of 79 cases. Acta Chir Belg. 1993;93:173-176. [PubMed] |
| 6. | Chatu S, Kumar D, Du Parcq J, Vlahos I, Pollok R. A rare cause of rectal bleeding masquerading as proctitis. J Crohns Colitis. 2013;7:e99-102. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2] [Cited by in RCA: 2] [Article Influence: 0.2] [Reference Citation Analysis (0)] |
| 7. | Djouhri H, Arrivé L, Bouras T, Martin B, Monnier-Cholley L, Tubiana JM. MR imaging of diffuse cavernous hemangioma of the rectosigmoid colon. AJR Am J Roentgenol. 1998;171:413-417. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 17] [Cited by in RCA: 20] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
| 8. | Aylward CA, Orangio GR, Lucas GW, Fazio VW. Diffuse cavernous hemangioma of the rectosigmoid--CT scan, a new diagnostic modality, and surgical management using sphincter-saving procedures. Report of three cases. Dis Colon Rectum. 1988;31:797-802. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 29] [Cited by in RCA: 28] [Article Influence: 0.7] [Reference Citation Analysis (0)] |
| 9. | Wang HT, Gao XH, Fu CG, Wang L, Meng RG, Liu LJ. Diagnosis and treatment of diffuse cavernous hemangioma of the rectum: report of 17 cases. World J Surg. 2010;34:2477-2486. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 26] [Cited by in RCA: 28] [Article Influence: 1.9] [Reference Citation Analysis (0)] |
| 10. | Cotzias E, Rehman SF, Arsalani Zadeh R, Smith D. Conservative management of diffuse cavernous haemangioma of the sigmoid and rectum. Ann R Coll Surg Engl. 2020;102:e1-e3. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 3] [Cited by in RCA: 2] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
| 11. | Pai M, Frampton AE, Virk JS, Nehru N, Kyriakides C, Limongelli P, Jackson JE, Jiao LR. Preoperative superselective mesenteric angiography and methylene blue injection for localization of obscure gastrointestinal bleeding. JAMA Surg. 2013;148:665-668. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 11] [Cited by in RCA: 16] [Article Influence: 1.2] [Reference Citation Analysis (0)] |
| 12. | Wiedmann M, Halm U, Borte G, Witzigmann H. [Recurrent lower gastro-intestinal bleeding in a 38-year-old patient]. Dtsch Med Wochenschr. 2002;127:1130-1133. [RCA] [PubMed] [DOI] [Full Text] [Reference Citation Analysis (0)] |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
